A new nanospray drying method for the preparation of nicergoline pure nanoparticles

Journal of Nanoparticle Research

Volumn 14, Issue 6, 2012, Pages

  Martena, Valentina ^a   Censi, Roberta ^a   Hoti, Ela ^b   Malaj, Ledjan ^b   Di Martino, Piera ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF TIRANA   (Albania)

Author keywords

Amorphous; Nanoparticles; Nanospray drying; Nicergoline

Indexed keywords

AMORPHOUS MATERIALS; CARBOXYLIC ACIDS; DIFFERENTIAL SCANNING CALORIMETRY; DRYING; NANOPARTICLES; NEGATIVE IMPEDANCE CONVERTERS; PYRIDINE; THERMODYNAMIC STABILITY;

AMORPHOUS CHARACTERS; DRYING METHODS; ETHANOL SOLUTIONS; NANOPARTICLE (NPS); NANOSPRAY; NICERGOLINE; SPRAY DRYERS; X-RAY POWDER DIFFRACTOMETRY;

DRUG DELIVERY;

NANOCRYSTAL; NANOPARTICLE; NICERGOLINE;

ARTICLE; COLLOID; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; GAS CHROMATOGRAPHY; LIGHT SCATTERING; NANOTECHNOLOGY; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

EID: 84861794302     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-012-0934-1     Document Type: Article

References (29)

1. C Ahlneck G Zografi 1990 The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state Int J Pharm 62 87 95 10.1016/0378-5173(90)90221-O 1:CAS:528:DyaK3cXlslyjurg%3D (Pubitemid 20261777)
2. V Andronis M Yoshioka G Zografi 1997 Effects of sorbed water on the crystallization of indomethacin from the amorphous state J Pharm Sci 86 346 351 10.1021/js9602711 1:CAS:528:DyaK2sXhtVGhtrs%3D (Pubitemid 27113770)
3. Banakar UV (1992) In: Swarbrick J (ed) Pharmaceutical dissolution testing. Marcel Dekker, New York, pp 55-105
4. Brossi A (1990) The alkaloids. Chemistry and pharmacology, 38. Academic Press Inc, San Diego, p 142
5. KJ Crowley G Zografi 2002 Water vapour absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions J Pharm Sci 90 2150 2165 10.1002/jps.10205
6. J Elversson A Millqvist-Fureby G Alderborn U Eloffson 2003 Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying J Pharm Sci 92 900 910 10.1002/jps.10352 1:CAS:528:DC%2BD3sXislOgsLs%3D (Pubitemid 36397005)
7. L Gao D Zhang M Chen 2008 Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system J Nanopart Res 10 845 862 10.1007/s11051-008-9357-4 1:CAS:528:DC%2BD1cXkvFajsbg%3D
8. D Goo E Palosi L Szporny 1988 Comparison of the effects of vinpocetine, vincamine, and nicergoline on the normal and hypoxia-damaged learning process in spontaneously hypertensive rats Drug Dev Res 15 75 85 10.1002/ddr.430150108 (Pubitemid 19159185)
9. T Hamaura JM Newton 1999 Interaction between water and poly(vinylpyrrolidone) containing polyethylene glycol J Pharm Sci 88 1228 1232 10.1021/js980354c 1:CAS:528:DyaK1MXmtlCksro%3D (Pubitemid 29526311)
10. BC Hancock M Parks 2000 What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 17 397 403 10.1023/A:1007516718048 1:CAS:528:DC%2BD3cXktFalsb0%3D (Pubitemid 30395293)
11. C Heitz JJ Descombes RC Miller JC Stoclet 1986 α-Adrenoceptor antagonistic and calcium antagonistic effects of nicergoline in the rat isolated aorta Eur J Pharmacol 123 279 285 10.1016/0014-2999(86)90669-2 1:CAS:528:DyaL28XktFyht7c%3D (Pubitemid 16055461)
12. ICH Topic Q 1 A (R2) (2003) Stability testing of new drug substances and products. Note for guidance on stability testing: stability testing of new drug substances and products. (CPMP/ICH/2736/99). EMEA, London, pp 1-20
13. JAH Junghanns RH Müller 2008 Nanocrystal technology, drug delivery and clinical applications Int J Nanomed 3 295 309 1:CAS:528:DC%2BD1cXhtlems7jF
14. Kontny MJ, Zografi G (1995) Sorption of water by solids. In: Brittain HG (ed) Physical characterization of pharmaceutical solids. Marcel Dekker, New York, pp 387-418
15. YF Maa PA Nguyen T Sweeney SJ Shire CC Hsu 1999 Protein inhalation powders: spray drying vs spray freeze drying Pharm Res 16 249 254 10.1023/A:1018828425184 1:CAS:528:DyaK1MXhvFyltr4%3D (Pubitemid 29135129)
16. L Malaj R Censi D Capsoni L Pellegrino M Bini S Ferrari R Gobetto V Massarotti P Di Martino 2011 Characterization of nicergoline polymorphs crystallized in several organic solvents J Pharm Sci 100 2610 2622 10.1002/jps.22477 1:CAS:528:DC%2BC3MXlslCgs7o%3D
17. Martena V, Censi R, Hoti E, Malaj L, Di Martino P (2011) Physicochemical characterization of nicergoline and cabergoline in its amorphous state. J Therm Anal Calorim doi: 10.1007/s10973-011-1954-2
18. R Mauludin RH Müller CM Keck 2009 Development of an oral rutin nanocrystal formulation Int J Pharm 370 202 209 10.1016/j.ijpharm.2008.11.029 1:CAS:528:DC%2BD1MXislKisbY%3D
19. Merisko-Liversidge E (2002) Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds. In: Marty JJ (Ed) Particles. Marcel Dekker, Orlando
20. A Noyes WR Whitney 1897 The rate of solution of solid substances in their own solutions J Am Chem Soc 19 930 934 10.1021/ja02086a003
21. O Pastoris L Vercesi F Allorio M Dossena 1988 Effect of hypoxia, aging and pharmacological treatment on muscular metabolites and enzyme activities Il Farmaco Ed Sci 43 627 642 1:CAS:528:DyaL1cXmt1Ontb0%3D (Pubitemid 18261466)
22. E Schmitt CW Davis ST Long 1996 Moisture-dependent crystallization of amorphous lamotrigine mesylate J Pharm Sci 85 1215 1219 10.1021/js9600484 1:CAS:528:DyaK28XmtFKisrw%3D (Pubitemid 26372891)
23. SL Shamblin G Zografi 1999 The effects of absorbed water on the properties of amorphous mixtures containing sucrose Pharm Res 16 1119 1124 10.1023/A:1018960405504 1:CAS:528:DyaK1MXltVyhsLw%3D (Pubitemid 29368163)
24. R Shegokar RH Müller 2010 Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives Int J Pharm 399 129 139 10.1016/j.ijpharm.2010.07.044 1:CAS:528:DC%2BC3cXhtFOisbzM
25. Speiser PP (1998) Poorly soluble drugs: a challenge in drug delivery. In: Benita S, Böhm B, Müller RH (eds) Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Medpharm Scientific Publishers, Stuttgart, pp 15-28
26. Taylor LS, Shamblin SL (2009) Amorphous solids. In: Brittain HG (ed) Polymorphism. Informa Healthcare, New York, pp 594-596
27. E Triulzi S Devizzi A Margonato 1981 Use of nicergoline in acute myocardial infarction with diastolic hypertension Il Farmaco (ed Prat) 36 449 455 1:STN:280:DyaL38%2FntlWnsA%3D%3D (Pubitemid 12179228)
28. Venn RD (1980) Review of clinical studies with ergots in gerontology. In: Goldstein M, Liberman A, Calne DB, Thorner MO (eds) Ergot compounds and brain function. Raven Press, New York, pp 363-377
29. G Zografi 1988 States of water associated with solids Drug Dev Ind Pharm 14 1905 1926 10.3109/03639048809151997 1:CAS:528:DyaL1cXlvFOktbk%3D